Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...
GlobalData on MSN
Abbott reports positive FREEDM2 study results for CGM
The study was carried out at 24 clinical sites across the UK and included 303 participants.
Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results